Discover 1,973 paid clinical trials in Fort Lauderdale, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,973
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
for
Mature B-cell Malignancies
Location: Plantation FL, Westbury NY
Sponsor: InnoCare Pharma Inc.
Sex: All
Age: 18+
Code: NCT06351527
Phase1, Recruiting
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
for
NSCLC, Non-small Cell Lung Cancer,
Location: Plantation FL
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07777822
Phase3, Recruiting
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
for
Non Small Cell Lung Cancer (Squamous or Non Squamous),
Location: Tamarac FL, Plantation FL, Daphne AL, Blacksburg VA,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07365319
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Hollywood FL, North Miami Beach FL, Boca Raton FL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase3, Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
for
Pneumococcal Disease
Location: North Lauderdale FL, Miami Lakes FL, Hialeah FL,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT07629440
Phase3, Recruiting
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
Location: Hollywood FL, Atlanta GA, Cooperstown NY, Gilbert AZ,
Sponsor: Alpha Tau Medical LTD.
Sex: All
Age: 18+
Code: NCT06615635
Recruiting
New
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
for
Chronic Pain, Low Back Pain
Location: Sunrise FL, Miami FL, Merritt Island FL, Bradenton FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07641504
Phase2, Recruiting
New
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
for
Osteoarthritis, Knee, Chronic Pain
Location: Sunrise FL, Miami FL, Merritt Island FL, Bradenton FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 40+
Code: NCT07641517
Phase2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
for
Hypercholesterolemia
Location: Sunrise FL, Fort Myers FL, Clearwater FL,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07477704
Phase2, Recruiting
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for
ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: Plantation FL, Fairfax VA, Houston TX,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18 - 70+
Code: NCT07540572
Phase1, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study